NCI Dictionary of Cancer Terms
A drug that is used to treat advanced prostate cancer and is also being studied in the treatment
of benign prostatic hyperplasia. Firmagon binds to gonadotropin-releasing hormone (GnRH)
receptors in the pituitary gland. This causes the body to stop making testosterone, which
prostate cancer needs to grow. Firmagon is a type of GnRH antagonist. Also called degarelix.